Synthetic phototransduction with a light-responsive molecule (KIO-301) in advanced retinitis pigmentosa: the ABACUS-1 phase 1/2 trial

Simple item page
dc.contributor.authorCasson, R.J.
dc.contributor.authorDaniels, E.
dc.contributor.authorBarras, C.
dc.contributor.authorDwyer, A.
dc.contributor.authorStrem, B.
dc.contributor.authorWykoff, C.C.
dc.contributor.authorVan Gelder, R.N.
dc.contributor.conferenceAnnual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) (5 May 2024 - 9 May 2024 : Seattle, WA, USA)
dc.date.issued2024
dc.description.statementofresponsibilityRobert James Casson, Eric Daniels, Christen Barras, Andrew Dwyer, Brian Strem, Charles Clifton Wykoff, Russell N Van Gelder
dc.identifier.citationInvestigative Ophthalmology and Visual Science, 2024, vol.65, iss.7, pp.407-1-407-3
dc.identifier.issn0146-0404
dc.identifier.issn1552-5783
dc.identifier.orcidCasson, R.J. [0000-0003-2822-4076]
dc.identifier.urihttps://hdl.handle.net/2440/143704
dc.language.isoen
dc.publisherAssociation for Research in Vision & Ophthalmology
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1099932
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
dc.source.urihttps://iovs.arvojournals.org/article.aspx?articleid=2794004
dc.titleSynthetic phototransduction with a light-responsive molecule (KIO-301) in advanced retinitis pigmentosa: the ABACUS-1 phase 1/2 trial
dc.typeConference item
pubs.publication-statusPublished

Files

Collections

Research Outputs